ENHANCEMENT OF THE IMMUNE IESPONSE OF CHICKENS VACCINATED WITH ADJUVANTED LIVE NEWCASTLE DISEASE VIRUS VACCINE
DOI:
https://doi.org/10.26873/SVR-1578-2022Keywords:
LaSota, NDV, vaccine, nanoparticles, adjuvant, challengeAbstract
The poultry industry depends heavily on immunization, particularly with live attenuated vaccines. These vaccines are commonly not adjuvanted and can be either injected or delivered in birds’ mucosa. In the current study we evaluated the protective efficacy of adjuvanted and non-adjuvanted live Newcastle disease virus (LaSota strain) vaccines. Three non-adjuvanted live NDV vaccines were used to vaccinate three groups of chickens. The same immunizations were administered to three additional groups employing adjuvant technology where a mucosal adjuvant (Montanide TM IMS 1313 nanoparticles) was used. Under experimental conditions, humoral and cellular immune responses were assessed, and challenge test was done for evaluation of the vaccine efficacy in the vaccinated chickens. RT qPCR was used for determination of viral shedding in oropharyngeal swabs of challenged chickens. Mucosal nanoparticles adjuvanted live NDV vaccines significantly improved the antibody titer and the cell mediated immune response in comparison with the non-adjuvanted ones. In the challenged chicken groups with highly virulent NDV sub-genotype VIId at the third week post vaccination, the Montanide adjuvanted vaccines were fully protective and prevention of virus shedding was also noticed while the protection rate of non-adjuvanted vaccines ranged from 90% to 100% and the virus shedding was reduced. The study indicated that, efficacy of live vaccines could be improved by using Montanide™ IMS 1313 nanoparticles adjuvant in a model of mucosal delivery of live NDV vaccine in chickens.
References
● 1. Ariyama N, Tapia R, Godoy C, et al. Avian orthoavulavirus 1 (Newcastle Disease virus) antibodies in five penguin species, Antarctic peninsula and Southern Patagonia. Transbound Emerg Dis. 2021; 68(6): 3096–102.
● 2. Moharam I, Razik AAE, Sultan H, et al. Investigation of suspected Newcastle disease (ND) outbreaks in Egypt uncovers a high virus velogenic ND virus burden in small-scale holdings and the presence of multiple pathogens. Avian Pathol. 2019; 48(5): 406–15.
● 3. Dimitrov KM, Afonso CL, Yu Q, Miller PJ. Newcastle disease vaccines-A solved problem or a continuous challenge? Vet Microbiol. 2017; 206: 126–36.
● 4. Abd El-Moneam MM, Fathy NA, Ali NI, El Naggar HM. Improvements to the live-attenuated Newcastle disease virus vaccine using Carbopol(®) 940 as a stabilizer. Vet World. 2020; 13(8): 1641–6.
● 5. Kapczynski DR, Afonso CL, Miller PJ. Immune responses of poultry to Newcastle disease virus. Dev Comp Immunol. 2013; 41(3): 447–53.
● 6. van Boven M, Bouma A, Fabri TH, Katsma E, Hartog L, Koch G. Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol. 2008; 37(1): 1–5.
● 7. Rauw F, Gardin Y, Palya V, et al. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol. 2010; 134(3-4): 249–58.
● 8. Deville S, Arous JB, Bertrand F, Borisov V, Dupuis L. Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry. Procedia Vaccinol. 2012; 6: 85–92.
● 9. Naggar HM, Madkour MS, Hussein HA. Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses. Vet World. 2017; 10(2): 187–93.
● 10. Wise MG, Suarez DL, Seal BS, et al. Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples. J Clin Microbiol. 2004; 42(1): 329–38.
● 11. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938; 27(3): 493–7.
● 12. OIE. OIE Terrestrial Manual. Newcastle Disease (Infectious with Newcastle disease virus) Ch. 3, 3, 14. . Paris, France. : World Organisation For Animal Health; 2021.
● 13. Lee LF. Chicken lymphocyte stimulation by mitogens: a microassay with whole-blood cultures. Avian Dis. 1978; 22(2): 296–307.
● 14. Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988; 48(17): 4827–33.
● 15. Radwan MM, Darwish SF, El-Sabagh IM, El-Sanousi AA, Shalaby MA. Isolation and molecular characterization of Newcastle disease virus genotypes II and VIId in Egypt between 2011 and 2012. Virus Genes. 2013; 47(2): 311–6.
● 16. 1Zhang L, Zhang M, Li J, Cao T, Tian X, Zhou F. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo. Res Vet Sci. 2008; 85(3): 495–502.
● 17. Al-Garib S, Gielkens A, Gruys E, Kochi G. Review of Newcastle disease virus with particular references to immunity and vaccination. Worlds Poult Sci J 2003; 59(2): 185–200.
● 18. Zhao K, Chen G, Shi XM, et al. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PLoS One. 2012; 7(12): e53314.
● 19. Ismail N, El-Deeb A, Emara M, Tawfik H, Wanis N, Hussein H. IMS 1313-nanoparticle mucosal vaccine enhances immunity against avian influenza and newcastle disease viruses. Int J Poult Sci 2018; 17(4): 167–74.
● 20. Jang SI, Lillehoj HS, Lee SH, et al. Montanide IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina. Vet Parasitol. 2011; 182(2-4): 163–70.
● 21. Sathish K, Sriraman R, NM P, et al. Oral immunization of birds against recombinant eimera antigens: An approach for vaccinating poultry birds against coccidiosis. Curr Trends Biotechnol Pharm 2012; 6(3): 312–21.
● 22. Reynolds DL, Maraqa AD. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis. 2000; 44(1): 138–44.
● 23. Reynolds DL, Maraqa AD. Protective immunity against Newcastle disease: the role of cell-mediated immunity. Avian Dis. 2000; 44(1): 145–54.
● 24. Alexander DJ, Senne DA. Newcastle disease, other avian paramyxoviruses, and pneumovirus infections. In: Saif YM, Fadly AM, Glisson JR, editors. Diseases of Poultry 12th ed: Ames: Blackwell Publishing Professional; 2008. p. 75–115.
● 25. Takada A, Kida H. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet Microbiol. 1996; 50(1-2): 17–25.
● 26. El-Dabae WH, Hussein HA, Rohaim MA, El-Safty MM, Ata NS, Reda IM. Saponin-adjuvanted vaccine protects chickens against velogenic Newcastle disease virus. Arch Virol. 2018; 163(9): 2423–32.
● 27. A Radwan A, Mikhael CA. Comparative Evaluation on The Efficacy of Embryonated Chicken Egg Adapted and Tissue Culture Pigeon Pox Vaccines Against The Local Virulent Strain. Journal of Applied Veterinary Sciences. 2020; 5(2): 87–93.
● 28. Ma X, Bi S, Wang Y, Chi X, Hu S. Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens. Poult Sci. 2019; 98(9): 3548–56.
● 29. Cardenas-Garcia S, Diel DG, Susta L, et al. Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines. Biologicals. 2015; 43(2): 136–45.
● 30. Cornax I, Miller PJ, Afonso CL. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype. Avian Dis. 2012; 56(3): 464–70.
● 31. Miller PJ, Afonso CL, El Attrache J, et al. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Dev Comp Immunol. 2013; 41(4): 505–13.
● 32. Kapczynski DR, King DJ. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine. 2005; 23(26): 3424–33.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 SLOVENIAN VETERINARY RESEARCH
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
